Skip to Content

Cerner Corp CERN

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Cerner Posts In Line Quarter and Commences Search for Next CEO; Expands Share Buyback Program

Dylan Finley Associate Equity Analyst

Analyst Note

| Dylan Finley |

In tandem with the earnings release, wide-moat Cerner dropped several noteworthy announcements, including the search for a new CEO. Current CEO Brent Shafer joined Cerner in 2018 and has helped lead the company forward in simplifying and improving the mix of services to better match the times by acquiring new technologies. Shafer and Cerner's board are in cooperation to place his successor, and this move follows several other shuffles in the C-suite over the past year. Cerner has made progress in clarifying its strategy and improving services, and seeks to continue to smooth out operations with a new chief. This move follows recent headwinds--it was announced in March 2021 that the Veteran's Association (VA) would temporarily pause the $16 billion rollout of its modernization project with Cerner, while a review is launched. The VA Inspector General has noted several issues with implementation thus far--partially as a result of the agency's preparedness--resulting in higher costs, delays, and frustration among clinicians. Cerner fully supports the VA's review and expects these near-term headwinds to cut 1% off 2021 revenue growth. In other news, Cerner announced an expansion in its capital return program, raising expectations to $1.5 billion in share buybacks in 2021 (versus prior guidance of $1 billion in February).

Read Full Analysis

Company Profile

Business Description

Cerner is a leading supplier of healthcare information technology solutions and tech-enabled services. The company offers a wide range of intelligent solutions and tech-enabled services that support the clinical, financial, and operational needs of healthcare organizations of varying sizes. The company employs nearly 30,000 associates and has a strong global installed base, including the lion's share of the top 100 health systems, physician practices, laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics, surgery centers, extended-care facilities, retail pharmacies, and employer sites. The company is guided by the mission of the founding partners to provide seamless medical records across all healthcare providers to improve outcomes.

2800 Rockcreek Parkway
North Kansas City, MO, 64117
T +1 816 221-1024
Sector Healthcare
Industry Health Information Services
Most Recent Earnings Mar 31, 2021
Fiscal Year End Dec 28, 2020
Stock Type Slow Growth
Employees 26,400


Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.